Crawford SR, Brown TM, Fehnel SE, Doward L, Nelson L, Chen A, Kim T, Roof E, Dykens EM. The international development of the modified hyperphagia questionnaire. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.
Hartry A, Francois C, Llorca PM, Lancon C, DiBenedetti D, Brown TM. Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications (AAP) in schizophrenia: the patient perspective. Poster presented at the 2015 US Psychiatric and Mental Health Congress (Psych Congress); September 10, 2015. San Diego, CA.
Hartry A, Francois C, Llorca PM, Lancon C, DiBenedetti D, Brown TM. Assessing the burden of treatment-emergent adverse events associated with Atypical Antipsychotic medications (AAPs) in Major Depressive Disorder (MDD): the patient perspective. Poster presented at the 2015 US Psychiatric and Mental Health Congress; September 2015. San Diego, CA.
Herman BK, Deal LS, DiBenedetti DB, Nelson LM, Fehnel SE, Brown TM. Development of the binge eating disorder screener. Poster presented at the 168th American Psychiatric Association Annual Meeting; May 16, 2015. Toronto, Canada.
Mordin M, Brown TM, McLeod L, DeMuro C, Gnanasakthy A. Two companies following the FDA pro guidance leads to similar but different measures: a case study in psoriasis. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.
Fehnel S, Brown TM, Nelson L, Chen A, Roof E, Kim DD, Dykens EM. Development of the hyperphagia questionnaire for use in prader-willi syndrome clinical trials. Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.
Deal LS, Sleeper-Triplett J, DiBenedetti DB, Nelson L, McLeod L, Haydysch EE, Brown TM. Development and validation of the ADHD Benefits of Coaching Scale (ABCS). J Atten Disord. 2015 Mar;19(3):191-9. doi: 10.1177/1087054714558118